| Dr Desiree M Quinones Maymi, MD | |
|
2435 Blvd Luis A Ferre, Hosp. Metropolitano Dr. Pila/depart. De Radiologia, Ponce, PR 00717-2112 | |
| (787) 848-5600 | |
| (787) 842-9324 |
| Full Name | Dr Desiree M Quinones Maymi |
|---|---|
| Gender | Female |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 2435 Blvd Luis A Ferre, Ponce, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063562346 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 14302 (Puerto Rico) | Primary |
| Entity Name | Caribe Physicians Plaza Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215051404 PECOS PAC ID: 0042246712 Enrollment ID: O20050713001119 |
News Archive
A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients, UT Southwestern Medical Center cancer researchers report.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
The need for professional care of African-American children with autism can go unmet. Some of the disparity could stem from cultural differences in parental perceptions of behavior, says autism expert Margaret C. Souders, PhD, RN, assistant professor of human genetics at Penn Nursing.
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.
Researchers from the Johns Hopkins Institute for NanoBioTechnology have been awarded $14.8 million from the National Cancer Institute to launch a research center aimed at unraveling the physical underpinnings of the growth and spread of cancer.
› Verified 7 days ago
| Entity Name | Centro Medico Del Turabo Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710107883 PECOS PAC ID: 9335051952 Enrollment ID: O20080212000105 |
News Archive
A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients, UT Southwestern Medical Center cancer researchers report.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
The need for professional care of African-American children with autism can go unmet. Some of the disparity could stem from cultural differences in parental perceptions of behavior, says autism expert Margaret C. Souders, PhD, RN, assistant professor of human genetics at Penn Nursing.
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.
Researchers from the Johns Hopkins Institute for NanoBioTechnology have been awarded $14.8 million from the National Cancer Institute to launch a research center aimed at unraveling the physical underpinnings of the growth and spread of cancer.
› Verified 7 days ago
| Entity Name | Insight Management Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891722989 PECOS PAC ID: 8527064062 Enrollment ID: O20100727000180 |
News Archive
A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients, UT Southwestern Medical Center cancer researchers report.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
The need for professional care of African-American children with autism can go unmet. Some of the disparity could stem from cultural differences in parental perceptions of behavior, says autism expert Margaret C. Souders, PhD, RN, assistant professor of human genetics at Penn Nursing.
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.
Researchers from the Johns Hopkins Institute for NanoBioTechnology have been awarded $14.8 million from the National Cancer Institute to launch a research center aimed at unraveling the physical underpinnings of the growth and spread of cancer.
› Verified 7 days ago
| Entity Name | Aguada Medical Center Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598057374 PECOS PAC ID: 0840462727 Enrollment ID: O20111019000410 |
News Archive
A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients, UT Southwestern Medical Center cancer researchers report.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
The need for professional care of African-American children with autism can go unmet. Some of the disparity could stem from cultural differences in parental perceptions of behavior, says autism expert Margaret C. Souders, PhD, RN, assistant professor of human genetics at Penn Nursing.
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.
Researchers from the Johns Hopkins Institute for NanoBioTechnology have been awarded $14.8 million from the National Cancer Institute to launch a research center aimed at unraveling the physical underpinnings of the growth and spread of cancer.
› Verified 7 days ago
| Entity Name | Rad Imaging Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609136506 PECOS PAC ID: 0547409641 Enrollment ID: O20130621000274 |
News Archive
A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients, UT Southwestern Medical Center cancer researchers report.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
The need for professional care of African-American children with autism can go unmet. Some of the disparity could stem from cultural differences in parental perceptions of behavior, says autism expert Margaret C. Souders, PhD, RN, assistant professor of human genetics at Penn Nursing.
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.
Researchers from the Johns Hopkins Institute for NanoBioTechnology have been awarded $14.8 million from the National Cancer Institute to launch a research center aimed at unraveling the physical underpinnings of the growth and spread of cancer.
› Verified 7 days ago
| Entity Name | Dla Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366890311 PECOS PAC ID: 4981986015 Enrollment ID: O20170124002548 |
News Archive
A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients, UT Southwestern Medical Center cancer researchers report.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
The need for professional care of African-American children with autism can go unmet. Some of the disparity could stem from cultural differences in parental perceptions of behavior, says autism expert Margaret C. Souders, PhD, RN, assistant professor of human genetics at Penn Nursing.
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.
Researchers from the Johns Hopkins Institute for NanoBioTechnology have been awarded $14.8 million from the National Cancer Institute to launch a research center aimed at unraveling the physical underpinnings of the growth and spread of cancer.
› Verified 7 days ago
| Entity Name | Dr Pedro Farinacci Morales Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780322933 PECOS PAC ID: 1850772955 Enrollment ID: O20220720003873 |
News Archive
A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients, UT Southwestern Medical Center cancer researchers report.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
The need for professional care of African-American children with autism can go unmet. Some of the disparity could stem from cultural differences in parental perceptions of behavior, says autism expert Margaret C. Souders, PhD, RN, assistant professor of human genetics at Penn Nursing.
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.
Researchers from the Johns Hopkins Institute for NanoBioTechnology have been awarded $14.8 million from the National Cancer Institute to launch a research center aimed at unraveling the physical underpinnings of the growth and spread of cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Desiree M Quinones Maymi, MD Ext. Quintas De Monserrate, 8 Calle 6, Ponce, PR 00730-1747 Ph: (787) 671-8959 | Dr Desiree M Quinones Maymi, MD 2435 Blvd Luis A Ferre, Hosp. Metropolitano Dr. Pila/depart. De Radiologia, Ponce, PR 00717-2112 Ph: (787) 848-5600 |
News Archive
A clinical trial that combined stereotactic body radiation therapy with a specific chemotherapy regimen more than doubled survival rates for certain stage 4 lung cancer patients, UT Southwestern Medical Center cancer researchers report.
Although oral hormonal therapy is known to substantially reduce breast cancer recurrence in women with hormone receptor-positive tumors, about one-half of patients fail to take their medications as directed. A new study by Columbia University Medical Center researchers has found that the introduction of generic aromatase inhibitors (the most common type of hormone therapy), which are considerably less expensive than their brand name counterparts, increased treatment adherence by 50 percent.
The need for professional care of African-American children with autism can go unmet. Some of the disparity could stem from cultural differences in parental perceptions of behavior, says autism expert Margaret C. Souders, PhD, RN, assistant professor of human genetics at Penn Nursing.
Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.
Researchers from the Johns Hopkins Institute for NanoBioTechnology have been awarded $14.8 million from the National Cancer Institute to launch a research center aimed at unraveling the physical underpinnings of the growth and spread of cancer.
› Verified 7 days ago
Yadira G Mateo, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 172 Calle Bianca, Urb Terra Senorial, Ponce, PR 00731 Phone: 787-365-0498 | |
Carlos Remedios-carbone, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Edif Parras # 203, Ponce, PR 00717 Phone: 787-813-4401 Fax: 787-813-4403 | |
Santiago N Sallaberry-morciglio, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 2225 Ponce Byp Ste 105, Ponce By Pass, Ponce, PR 00717 Phone: 787-843-3080 Fax: 787-259-1585 | |
Dr. Miguel Angel Echevarria Rodriguez, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1326 Salud St, El Senorial Plaza Suite 105, Ponce, PR 00728 Phone: 787-840-3395 Fax: 787-844-2664 | |
Victor A Berdecia Perez, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2435 Ave Las Americas, Hosp Dr Pila Dept De Radiologia, Ponce, PR 00733 Phone: 787-848-5600 Fax: 787-843-9320 | |
Ramiro Milan Garces, MD Radiology Medicare: Medicare Enrolled Practice Location: 2435 Ave Las Americas, Hosp Dr Pila Dept Radologia, Ponce, PR 00733 Phone: 787-848-5600 Fax: 787-843-9320 |